Urological Research

, Volume 31, Issue 3, pp 207–211

Cystine crystal volume determination: a useful tool in the management of cystinuric patients

  • Michel Daudon
  • Fabrice Cohen-Solal
  • Frédéric Barbey
  • Marie-France Gagnadoux
  • Bertrand Knebelmann
  • Paul Jungers
Original Article


We prospectively determined cystine crystal volume (Vcys) in urine specimens from all consecutive patients with cystine urolithiasis followed at our institution over the past decade, in order to assess its predictive value as to the risk of recurrent cystine stone formation. A total of 57 patients (29 males, 28 females) with homozygous cystinuria entered in the study between January 1990 and December 2000, including 15 children aged less than 15 years and 42 patients aged 15 years or more. The clinical and radiological course was followed until December 2001, for a total of 243 patient-years of follow-up. From study entry until the end of follow-up, we serially examined first voided morning urine specimens in all patients, with determination of the number of cystine crystals per mm3, and the average size of crystals, thus allowing us to calculate Vcys using a simple formula based on crystal geometry. Recurrence was diagnosed on the basis of serial radiographic examinations using X-rays and echography. Overall, cystine crystals were present in 179 (39%) of the 460 examined urine specimens. Cystine crystalluria was significantly more frequent among the 27 patients who developed new cystine stones (SF) than in the other 30 who remained stone-free (63.3 vs 25.5% of samples, P<0.001). The presence of crystals in ≥50% of serially examined urine samples was more frequently found in patients with recurrent stone formation than in non-recurrent patients (24/27 vs 2/30, P<0.001). The average Vcys value was significantly higher in recurrent SF than in stone-free patients (8,173±1,544 vs 233±150 µ3/mm3, P<0.001) and there was no overlap in the individual values of recurrent vs stone-free patients. A Vcys value ≥3,000 µ3/mm3 was observed at least once prior to each of the 63 stone recurrences observed in 27 patients (2.3 per patient on the average). In addition, Vcys reflected the efficacy of treatment, with Vcys mean values of 12,097±3,214 µ3/mm3 at baseline, falling to 2,648±658 µ3/mm3 on basic therapy (hyperdiuresis plus alkalinization) alone, 1,141±522 µ3/mm3 on tiopronin therapy (median dose 1,000 mg/day) and 791±390 µ3/mm3 on D-penicillamine therapy (median dose 900 mg/day) whereas captopril had no effect (5,114±2,128 µ3/mm3). Based on the results of the present study, cystine crystalluria appears to accurately reflect active stone formation in cystinuric patients. Determination of total Vcys provides a simple, cheap and accurate means of predicting the risk of cystine stone recurrence with a Vcys value ≥3000 µ3/mm3 as the threshold risk value. We propose that serial Vcys determination be performed simultaneously with the measurement of urine pH and specific gravity to optimally monitor the medical treatment of cystine patients.


Cystinuria Cystine crystal volume Alkalinization Diuresis Sulfhydriles Stone recurrence 


  1. 1.
    Assimos DG, Leslie SW, NG C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168: 27PubMedGoogle Scholar
  2. 2.
    Barbey F, Joly D, Rieu P, Méjean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163: 1419PubMedGoogle Scholar
  3. 3.
    Chow GK, Streem SB (1996) Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 16: 435Google Scholar
  4. 4.
    Coe FL, Clark C, Parks JH, Asplin JR (2001) Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol 166: 688PubMedGoogle Scholar
  5. 5.
    Cohen TD, Streem SB, Hall P (1995) Clinical effect of captopril on the formation and growth of cystine calculi. J Urol 154: 164PubMedGoogle Scholar
  6. 6.
    Crawhall JC (1987) Cystinuria—an experience in management over 18 years. Miner Electrolyte Metab 13: 286PubMedGoogle Scholar
  7. 7.
    Crawhall JC, Scowen EF, Watts RWE (1963) Effects of penicillamine on cystinuria. Br Med J 1: 588Google Scholar
  8. 8.
    Dahlberg PJ, Jones JD (1989) Cystinuria: failure of captopril to reduce cystine excretion. Arch Intern Med 149: 713CrossRefPubMedGoogle Scholar
  9. 9.
    Dahlberg PJ, Van Den Berg CJ, Kurtz SB, Wilson DM, Smith LH (1977) Clinical features and management of cystinuria. Mayo Clin Proc 52: 533PubMedGoogle Scholar
  10. 10.
    Dent C, Senior B (1955) Studies on the treatment of cystinuria. Br J Urol 27: 317Google Scholar
  11. 11.
    Dent C, Friedman M, Green H, Watson L (1965) Treatment of cystinuria. Br Med J 1: 403Google Scholar
  12. 12.
    Fjellstedt E, Denneberg T, Jeppsson JO, Christensson A, Tiselius HG (2001) Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria. Urol Res 29: 303CrossRefPubMedGoogle Scholar
  13. 13.
    Fjellstedt E, Denneberg T, Jeppsson JO, Tiselius HG (2001) A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria. Urol Res 29: 295PubMedGoogle Scholar
  14. 14.
    Gambaro G, Favaro S, D'Angelo A (2001) Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37: 233PubMedGoogle Scholar
  15. 15.
    Joly D, Rieu P, Méjean A, Gagnadoux MF, Daudon M, Jungers P (1999) Treatment of cystinuria. Pediatr Nephrol 13: 945PubMedGoogle Scholar
  16. 16.
    Lindell A, Denneberg T, Jeppsson JO (1995) Urinary excretion of free cystine and the tiopronin-cystein-mixed disulfide during long-term tiopronin treatment of cystinuria. Nephron 71: 328PubMedGoogle Scholar
  17. 17.
    Lindell A, Denneberg T, Jeppsson JO, Tiselius HG (1995) Measurement of diurnal variations in urinary cystine saturation. Urol Res 23: 215PubMedGoogle Scholar
  18. 18.
    Lindell A, Denneberg T, Granerus G (1997) Studies on renal function in patients with cystinuria. Nephron 77: 76PubMedGoogle Scholar
  19. 19.
    Michelakakis H, Delis D, Anastasiadou V, Bartsocas C (1993) Ineffectiveness of captopril in reducing cystine excretion in cystinuric children. J Inherit Metab Dis 16: 1042PubMedGoogle Scholar
  20. 20.
    Monnens LA, Noordam K, Trijbels F (2000) Necessary practical treatment of cystinuria at night. Pediatr Nephrol 14: 1148PubMedGoogle Scholar
  21. 21.
    Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL (2000) Clinical use of cystine supersaturation measurements. J Urol 164: 1481PubMedGoogle Scholar
  22. 22.
    Pak CYC, Fuller CJ (1983) Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol 129: 1066PubMedGoogle Scholar
  23. 23.
    Pak CYC, Fuller C, Sakhaee K, Zerwekh JE, Adams B (1986) Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 136: 1003PubMedGoogle Scholar
  24. 24.
    Pietrow PK, Auge BK, Weizer AZ, Delvecchio FC, Silverstein AD, Mathias B, Albala DM, Preminger GM (2003) Durability of the medical management of cystinuria. J Urol 169: 68PubMedGoogle Scholar
  25. 25.
    Rodman JS, Blackburn P, Williams JJ, Brown A, Pospischil MA, Peterson CM (1984) The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol 22: 273PubMedGoogle Scholar
  26. 26.
    Sakhaee K (1996) Pathogenesis and medical management of cystinuria. Semin Nephrol 16: 435PubMedGoogle Scholar
  27. 27.
    Singer A, Das S (1989) Cystinuria: a review of the pathophysiology and management. J Urol 142: 669PubMedGoogle Scholar
  28. 28.
    Sloand JA, Izzo JLJr (1987) Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med 147: 1409CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Michel Daudon
    • 1
  • Fabrice Cohen-Solal
    • 1
  • Frédéric Barbey
    • 2
  • Marie-France Gagnadoux
    • 3
  • Bertrand Knebelmann
    • 4
  • Paul Jungers
    • 4
  1. 1.Laboratoire de Biochimie AGroupe Hospitalier Necker-Enfants Malades75743 Paris Cedex 15
  2. 2.Service de Néphrologie-HémodialyseHôpital Cantonal
  3. 3.Service de Néphrologie PédiatriqueGroupe Hospitalier Necker-Enfants Malades
  4. 4.Service de Néphrologie AdultesGroupe Hospitalier Necker-Enfants Malades

Personalised recommendations